Cargando…
SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain
BACKGROUND: Neuropathic pain is experienced worldwide by patients suffering from nerve injuries, infectious or metabolic diseases or chemotherapy. However, the treatment options are still limited because of low efficacy and sometimes severe side effects. Recently, the deficiency of FKBP51 was shown...
Autores principales: | Wedel, Saskia, Mathoor, Praveen, Rauh, Oliver, Heymann, Tim, Ciotu, Cosmin I., Fuhrmann, Dominik C., Fischer, Michael J. M., Weigert, Andreas, de Bruin, Natasja, Hausch, Felix, Geisslinger, Gerd, Sisignano, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552419/ https://www.ncbi.nlm.nih.gov/pubmed/36217203 http://dx.doi.org/10.1186/s12974-022-02615-7 |
Ejemplares similares
-
SAFit2 ameliorates paclitaxel-induced neuropathic pain by reducing spinal gliosis and elevating pro-resolving lipid mediators
por: Wedel, Saskia, et al.
Publicado: (2023) -
The FKBP51 Inhibitor SAFit2 Restores the Pain-Relieving C16 Dihydroceramide after Nerve Injury
por: Wedel, Saskia, et al.
Publicado: (2022) -
The Lipid Receptor G2A (GPR132) Mediates Macrophage Migration in Nerve Injury-Induced Neuropathic Pain
por: Osthues, Tabea, et al.
Publicado: (2020) -
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
por: Sisignano, Marco, et al.
Publicado: (2022) -
Sex differences in the effect of the FKBP5 inhibitor SAFit2 on anxiety and stress-induced reinstatement following cocaine self-administration
por: Connelly, Krista L., et al.
Publicado: (2020)